Research ArticlePredictors of Achieving Remission among Patients with Psoriatic Arthritis Initiating a Tumor Necrosis Factor Inhibitor
Predictors of Achieving Remission among Patients with Psoriatic Arthritis Initiating a Tumor Necrosis Factor Inhibitor
Alexis Ogdie, J. Lynn Palmer, Jeffrey Greenberg, Jeffrey R. Curtis, Leslie R. Harrold, Daniel H. Solomon, Arthur Kavanaugh, Joel M. Kremer and Philip J. Mease
The Journal of Rheumatology May 2019, 46 (5) 475-482; DOI: https://doi.org/10.3899/jrheum.171034
Alexis Ogdie
From the University of Pennsylvania, Philadelphia, Pennsylvania; Corrona Research Foundation; New York University Hospital for Joint Diseases, New York, New York; University of Alabama at Birmingham, Birmingham, Alabama; University of Massachusetts, Worcester; Brigham and Women’s Hospital, Boston, Massachusetts; University of California San Diego, San Diego, California; Albany Medical College, Albany, New York; Swedish Medical Center; University of Washington, Seattle, Washington,
USA.
J. Lynn Palmer
Jeffrey Greenberg
Jeffrey R. Curtis
Leslie R. Harrold
Daniel H. Solomon
Arthur Kavanaugh
Joel M. Kremer
Data supplements
Data Supplement
In this issue
The Journal of Rheumatology
Vol. 46, Issue 5
1 May 2019
Predictors of Achieving Remission among Patients with Psoriatic Arthritis Initiating a Tumor Necrosis Factor Inhibitor
Alexis Ogdie, J. Lynn Palmer, Jeffrey Greenberg, Jeffrey R. Curtis, Leslie R. Harrold, Daniel H. Solomon, Arthur Kavanaugh, Joel M. Kremer, Philip J. Mease
The Journal of Rheumatology May 2019, 46 (5) 475-482; DOI: 10.3899/jrheum.171034
Predictors of Achieving Remission among Patients with Psoriatic Arthritis Initiating a Tumor Necrosis Factor Inhibitor
Alexis Ogdie, J. Lynn Palmer, Jeffrey Greenberg, Jeffrey R. Curtis, Leslie R. Harrold, Daniel H. Solomon, Arthur Kavanaugh, Joel M. Kremer, Philip J. Mease
The Journal of Rheumatology May 2019, 46 (5) 475-482; DOI: 10.3899/jrheum.171034